- Home
- CANG vs CTMX Comparison
CANG vs CTMX Comparison
Compare CANG & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANG
- CTMX
- Stock Information
- Founded
- CANG 2010
- CTMX 2008
- Country
- CANG China
- CTMX United States
- Employees
- CANG N/A
- CTMX N/A
- Industry
- CANG Computer Software: Prepackaged Software
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- CANG Technology
- CTMX Health Care
- Exchange
- CANG Nasdaq
- CTMX Nasdaq
- Market Cap
- CANG 462.1M
- CTMX 444.3M
- IPO Year
- CANG 2018
- CTMX 2015
- Fundamental
- Price
- CANG $5.24
- CTMX $2.41
- Analyst Decision
- CANG
- CTMX Strong Buy
- Analyst Count
- CANG 0
- CTMX 2
- Target Price
- CANG N/A
- CTMX $5.00
- AVG Volume (30 Days)
- CANG 440.1K
- CTMX 2.6M
- Earning Date
- CANG 08-28-2025
- CTMX 08-07-2025
- Dividend Yield
- CANG N/A
- CTMX N/A
- EPS Growth
- CANG N/A
- CTMX 128.27
- EPS
- CANG 0.00
- CTMX 0.49
- Revenue
- CANG $247,219,627.00
- CTMX $147,557,000.00
- Revenue This Year
- CANG $431.64
- CTMX N/A
- Revenue Next Year
- CANG $23.36
- CTMX N/A
- P/E Ratio
- CANG $2,769.28
- CTMX $5.15
- Revenue Growth
- CANG 46.60
- CTMX 23.81
- 52 Week Low
- CANG $1.40
- CTMX $0.40
- 52 Week High
- CANG $9.66
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- CANG 62.58
- CTMX 57.13
- Support Level
- CANG $4.26
- CTMX $2.15
- Resistance Level
- CANG $4.62
- CTMX $2.44
- Average True Range (ATR)
- CANG 0.29
- CTMX 0.22
- MACD
- CANG 0.05
- CTMX -0.03
- Stochastic Oscillator
- CANG 92.68
- CTMX 41.67
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and related businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives majority of its revenue from the bitcoin mining business.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.